期刊文献+

p53和c-erbB-2型在卵巢上皮性癌中的表达及其临床意义 被引量:2

SIGNIFICANCE OF EXPRESSION OF p 53 AND c-erbB-2 IN OVARIAN EPITHELIAL CARCINOMA
下载PDF
导出
摘要 目的探讨卵巢上皮性癌(简称卵巢癌)p53和cerbB2表达的临床意义。方法用免疫组织化学法检测p53和cerbB2,结合临床病理及肿瘤的生物学行为进行分析。结果p53在高分化卵巢癌中的表达频率显著低于中、低分化癌,p53表达阳性组的卵巢癌对化疗不敏感,其预后亦明显劣于阴性组卵巢癌。卵巢癌的cerbB2表达与临床期别、组织学类型和分级、残余瘤大小、化疗疗效和预后均无显著相关性。结论p53是评价卵巢癌化疗耐药性和预后的可靠指标。 ObjectiveTo explore the clinical significance of p 53 and c erbB 2 expression in ovarian epithelial carcinoma.MethodsThe expression of p 53 and c erbB 2 were examined by immunohistochemical method,and the relationship between the expression of two factors and clinicopathologic features resistant to chemotherapy and prognosis were analyzed.ResultsThe expression p 53 had significant lower frequency in well differentiated ovarian tumor than that in medium and poor differentiated one.p 53 positive tumors related with drug resistance and poor prognosis significantly.The expression of c erbB 2 was not associated with clinical stage,histologic type,grade, residual tumor,chemotherapy and prognosis.Conclusionp 53 expression in ovarian cancer is related to drug resistance,and it is a useful prognostic index.
出处 《河北医科大学学报》 CAS 2000年第2期87-89,共3页 Journal of Hebei Medical University
关键词 卵巢肿瘤 P53蛋白质 上皮性癌 代谢 药物疗法 ovarian neoplasms/metab protein p 53 /metab oncogene/immunol histological technics ovarian neoplasms/drug ther drug tolerance
  • 相关文献

参考文献3

二级参考文献15

  • 1Michael Fullan, The New Pedagogy: Students and Teachers as Learning Partners[J]. Learning Landscapes ,2013,6(2):23-29.
  • 2Fullan, M & Donnelly, K. IDC IVIEW report "Extracting value from chaos",Alive in the Swamp[R]. London: Nesta.2013.
  • 3Much More about MOOCs [DB/OL]. [2015-04-25].http:/,'harvard- magazine.corn/2015/04/harvard -mooc-online-leaming-lessons-from- edx.
  • 4Larry Hardesty. Lessons learned from MITx's prototype course[DB/ OL]. [2016 -02 -29].http://news.mit.edu/201.2/mitx -edx -first -course - rocap-0716.
  • 52015 cis regional conference[DB/OL].[2016-02-09].http://www.shane- mason.com/category/flipped-classroond.
  • 6Phol. Learning to Think, Thinking to Learn [DB/OL]. [2016-02-29].http://www.kurwongbss.qld.edu.au/thinking/Bloom/blooms.htm.
  • 7Marton, F.& Salja,R.. On qualitative differences in learning-- I: out- come and process [J]. British Journal of Educational Psychology, 1976,46,1: 4-11.
  • 8Marton, F. & Saljii, R. On qualitative differences in learning--II: out- come as a function of the learner's conception of the task [J]. British Journal of Educational Psychology, 1976,46,2:115-127.
  • 9Biggs, J. Teaching for desired learning outcomes. In N. Entwistle (Ed.)[M]// Handbook of educational ideas and practices. London: Routledge, 1990:681-693.
  • 10Ramsden, P. Learning to teach in higher education (2nd ed.)[M]. London: Routledge Falmer, 2003.

共引文献157

同被引文献15

  • 1徐晓云,李彬,王凤安.血清p53抗体与肿瘤[J].河北医科大学学报,2005,26(2):148-150. 被引量:4
  • 2[1]Johnson SW,Ozols RF,Hamilton TC.Mechanisms of drug resistance in ovarian cancer[J].Cancer,1993,71(2 Suppl):644-649.
  • 3[2]Johnson SW,Laub PB,Beesley JB,et al.Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines[J].Cancer Res,1997,57(5)850-856.
  • 4[3]Shelling AN,Cooke IE,Ganesan TS.The genetic analysis of ovarian cancer[J].Br J Cancer,1995,72(3):521-527.
  • 5[4]Anthoney DA,Mcllwrath AJ,Gallagher TS,et al.Microsatellite instability,apoptosis,and loss of P53 function in drug-resistance tumor cells[J].Cancer Res,1996,56(6):1374-1381.
  • 6[5]Fajac A,Da-Silva J,Ahomadegbe JC, et al.Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line[J].Int J Cancer,1996,68(1):67-74.
  • 7[7]Sato S,Kigawa J,Minagawa Y,et al.Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma[J].Cancer,1999,86(7):1307-1313.
  • 8[8]Kanamori Y,Kigawa J,Minagawa Y, et al.A newly developed adenovirus-mediated transfer of a wild-type p53 gene increase sensitivity to cisdiamminedichloroplatinum in p53 deleted ovarian cancer cells[J].Eur J Cancer,1998,34(11):1802-1806.
  • 9[9]Smets LA.Programmed cell death (apoptosis)and respone to anticancer-drugs[J].Anticancer Drugs,1994,5(1):3-9.
  • 10[10]Lowe Sw,Ruley He,Jacks T, et al .P53-dependent apoptosis modulates the cytotoxity of anticancer anticancer agents[J].Cell,1993,74(6):957-967.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部